A key body has unanimously agreed the Phase 2 trial of Recce’s lead compound for acute bacterial skin and skin-structure ...
Vous n'êtes pas connecté
A Phase II clinical trial for acute bacterial skin and skin structure infections reaches a dosing milestone. ...
A key body has unanimously agreed the Phase 2 trial of Recce’s lead compound for acute bacterial skin and skin-structure ...
Competitive: ICON Plc: Clinical Trial Recruitment Representative II ICON plc is a world-leading healthcare intelligence and clinical research...
Competitive: ICON Plc: Clinical Research Physician II - Hungary, Budapest Office-based ICON plc is a world-leading healthcare intelligence and...
Competitive: ICON Plc: Clinical Study Manager- Phase I Research ICON plc is a world-leading healthcare intelligence and clinical research...
Repare Therapeutics Inc., a leading clinical─stage precision oncology company, presented updated data highlighting the benefits of its...
Competitive: Fortrea: As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical...
Competitive: Fortrea: As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical...
On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December...
MONDAY, Oct. 28, 2024 -- An experimental electric bandage might help doctors stop bacterial infections without using any drugs, a new study...